Activity Provided By:

Postgraduate Institute for Medicine and PlatformQ Health Education, LLC (PQHE)

A Critical Update for the Multidisciplinary Team in Differentiating and Tailoring Management of Sarcomas

Overview / Abstract:	Target Audience This activity is intended for community-based and academic/specialist hematologists, medical oncologists, hematologic oncologists, pathologists, radiologic oncologists, surgical oncologists, primary care providers, oncology nurses and nurse navigators, nurse practitioners, physician assistants, and pharmacists. Learning Objectives At the conclusion of this activity, participants will be able to: Discuss coordination of care and clinical strategies to decrease the time to diagnosis for patients with rare cancers and blood disorders Integrate patient-centered and evidence-based treatment options for rare cancers and blood disorders Review emerging therapies under investigation as treatment options Evaluate management strategies of adverse events to improve patient outcomes Facilitate informed and shared decision-making through access to disease-related and support resources
Expiration	Nov 12, 2021
Discipline(s)	Nursing CNE, Pharmacy CPE, Physician CME
Format	Online
Credits / Hours	2.0 AMA PRA Category 1 Credit(s)™
Accreditation	ACCME
Presenters / Authors / Faculty	Faculty Catherine M. Broome, MD Associate Professor of Medicine MedStar Georgetown University Lombardi Cancer Center Steven Horwitz, MD Attending Physician Memorial Sloan Kettering Cancer Center Ayalew Tefferi, MD Professor of Hematology and Internal Medicine Division of Hematology Mayo Clinic College of Medicine in Rochester Minnesota Robert J. Kreitman, MD Hairy Cell Leukemia Bethesda, Maryland Jonathan C. Trent, MD, PhD Professor of Medicine Associate Director, Clinical Research Leader, Sarcoma Multidisciplinary Group Sylvester Comprehensive Cancer Center Miller School of Medicine University of Miami Lori J. Wirth, MD Elizabeth and Michael Ruane Endowed Chair of Medical Oncology Associate Professor of Medicine, Harvard Medical School Medical Director, Head and Neck Oncology Massachusetts General Hospital Jonathan Strosberg, MD Professor Moffitt Cancer Center Michael C. Heinrich, MD, FACP Professor of Medicine Professor of Cell, Developmental and Cancer Biology OHSU Knight Cancer Institute Ghassan Abou-Alfa, MD, MBA Professor Memorial Sloan Kettering Cancer Center
Sponsors / Supporters / Grant Providers	Daiichi Sankyo, Inc.; Deciphera Pharmaceuticals, LLC.; Eisai Inc.; Epizyme Inc.; Innate Pharma, Inc.; Ipsen Biopharmaceuticals, Inc.; Karyopharm Therapeutics; Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.; Sanofi Genzyme; and Seattle Genetics, Inc
Keywords / Search Terms	Relias LLC Relias LLC., FREE CME, Sarcomas Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map